Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2020 Oct;29(10):1949–1954. doi: 10.1158/1055-9965.EPI-20-0007

Table 2.

Comparisons of 2007–2011 cancer mortality rates for the entire U.S. versus counties defined by persistent poverty.

Non-Persistent Poverty (ref) Persistent Poverty Unadjusted difference Adjusted difference
mean SE mean SE % diff est. p est. p
All cancer types 179.3 0.6 201.3 1.8 12.3 22.0 <.0001 8.3 <.0001
Lung and bronchus 52.3 0.3 60.9 1.0 16.5 8.6 <.0001 2.9 <.001
Colorectal 17.1 0.1 20.1 0.3 17.7 3.0 <.0001 1.7 <.0001
Breast 21.6 0.2 24.1 0.5 11.9 2.6 <.0001 0.9 0.10
Prostate 22.8 0.2 28.2 0.7 24.0 5.5 <.0001 1.1 0.08
Cervical 2.5 0.1 3.7 0.2 50.1 1.2 <.0001 0.4 0.07
Oropharyngeal 2.5 0.0 3.2 0.1 29.6 0.7 <.0001 0.1 0.38
Stomach 2.9 0.0 4.1 0.2 43.2 1.3 <.0001 0.4 0.01
Liver and intrahepatic bile duct 5.0 0.1 6.3 0.2 27.6 1.4 <.0001 0.5 <.01

Note. Cancer mortality rates are expressed as deaths per 100,000 people per year, except breast and cervical cancers (deaths per 100,000 females per year) and prostate cancer (deaths per 100,000 males per year). Two-sample t-tests were used to estimate unadjusted differences in cancer mortality rates for counties not in persistent poverty (reference category) versus counties in persistent poverty, and multivariable linear regressions were used to estimate adjusted differences in cancer mortality rates. Adjusted models controlled for county-level metropolitan status; Census region; percent of residents that are female, Non-Hispanic black, Hispanic, with a bachelor’s degree or higher, and unemployed; and median household income. Ref=reference; SE=standard error; diff=difference; est.=parameter estimate.